HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Carbarsone

HCID 8480
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
121-59-5
Standard SMILES
NC(=O)Nc1ccc([As](=O)(O)O)cc1
InChIKey
WWXBHTZSYYGCSG-UHFFFAOYSA-N
Molecular formula
C7H9AsN2O4
Average molar mass
260.08 g/mol
Monoisotopic mass
259.977826

Overview

Carbarsone appears as white powder or solid. (NTP, 1992)

Names & identifiers

Preferred name
Carbarsone
IUPAC
[4-(carbamoylamino)phenyl]arsonic acid
English name
CARBARSONE
Molecular formula
C7H9AsN2O4
Molecular weight
260.08

Names & synonyms

Carbarsone121-59-5CarbarsonPentarsoneAmebanN-Carbamoylarsanilic acid[4-(carbamoylamino)phenyl]arsonic acidArsanilic acid, N-carbamoyl-CarbasoneBenzenearsonic acid, p-ureido-DTXSID40202464-Ureidobenzenearsonic acid
Show more names
kutanArsuranAMABEVANNSC32868aminarsonARSAMBIDEFENARSONE
8PK70TXE1TNSC-32868Arsonic acid, (4-((aminocarbonyl)amino)phenyl)-DTXCID80246Arsonic acid, [4-[(aminocarbonyl)amino]phenyl]-(4-(carbamoylamino)phenyl)arsonic acidCarbasonRefChem:123486

Database identifiers

CAS
121-59-5
PubChem CID
8480
DTXSID
DTXSID4020246
ChEMBL
CHEMBL1331366
ChEBI
CHEBI:94806
UNII
8PK70TXE1T
EC Number
204-484-6
Nikkaji
J5.340F

Properties

Computed structural propertiesFilling in

Topological polar surface area
113 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
4
Rotatable bonds
2
Heavy atoms
14
Formal charge
0
Complexity
256

Experimental & physicochemical properties

Solubility1 to 10 mg/mL at 71.1 °F (NTP, 1992)
Melting Point345 °F (NTP, 1992)
Physical DescriptionCarbarsone appears as white powder or solid. (NTP, 1992)

Physicochemical properties

Melting point
174 ° · 174°
solubility
DMSO (Slightly), Methanol (Slightly, Sonicated)
form
solid
pka
3.78 · 3.78±0.10(Predicted)
Stability
Hygroscopic
InChI
InChI=1S/C7H9AsN2O4/c9-7(11)10-6-3-1-5(2-4-6)8(12,13)14/h1-4H,(H3,9,10,11)(H2,12,13,14)
InChIKey
WWXBHTZSYYGCSG-UHFFFAOYSA-N
SMILES
C1([As](O)(O)=O)=CC=C(NC(N)=O)C=C1
REACH Annex XVII Substances List
Carbarsone (121-59-5)
FDA UNII
8 PK70TXE1T · 8PK70TXE1T
EPA Substance Registry System
Carbarsone (121-59-5)
Symbol(GHS)
9 · GHS09,GHS06
Signal word
Danger
Hazard statements
331 · H331-H301-H410
Precautionary statements
261 · P261-P271-P304+P340-P311-P321-P403+P233-P405-P501-P264-P270-P301+P310-P321-P330-P405-P501-P273-P391-P501

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P270, P271, P273, P301+P316, P304+P340, P316, P321, P330, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationRestricted substance: Carbarsone
Other Safety InformationIMAP assessments - Arsonic acid, [4-[(aminocarbonyl)amino]phenyl]-: Environment tier I assessment
DOT LabelPoison
Fire HazardsFlash point data for this chemical are not available; however, it is probably combustible. (NTP, 1992)
Health HazardsSYMPTOMS: Symptoms associated with arsenic compounds include irritation of the gastrointestinal tract, nausea, vomiting and diarrhea. In extreme cases, there may be blood in the vomitus and stool, rapid weak pulse, collapse, coma and death.
Reactive GroupAmides and Imides
Reactivity Profile · 1 item

An acidic salt of an amide. Materials in this group are generally soluble in water. The resulting solutions contain moderate concentrations of hydrogen ions and have pH's of less than 7.0. They react as acids to neutralize bases. These neutralizations generate heat, but less or far less than is generated by neutralization of inorganic acids, inorganic oxoacids, and carboxylic acid. They usually do not react as either oxidizing agents or reducing agents but such behavior is not impossible. Many of these compounds catalyze organic reactions.

Air and Water ReactionsSlightly soluble in water.
Hazard Classes and CategoriesAcute Tox. 3 (100%)

Safety & protection

Fire FightingFires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
First Aid · 1 item

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 item

SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Isolation and EvacuationExcerpt from ERG Guide 151 [Substances - Toxic (Non-Combustible)]:
Minimum Risk LevelAcute Oral: 0.005 mg/kg/day (L134) Chronic Oral: 0.0003 mg/kg/day (L134) Chronic Inhalation: 0.01 mg/m3 (L134)
Personal Protective Equipment (PPE) · 1 item

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

Toxicology

TreatmentAggressive decontamination with gastric lavage is recommended if the patient has consumed a potentially life-threatening dose and if the patient is not vomiting .
Health Effects · 1 item

Hypovolemia from capillary leakage (third-spacing of fluids) is a common, serious, early effect. Muscle cramps, facial edema, bronchitis, dyspnea, chest pain, dehydration, intense thirst, and fluid-electrolyte disturbances are also common following significant exposures. A garlic-like odor of the breath and feces may also occur. After absorption, arsenic may cause multi-organ failure by inhibiting sulfhydryl-containing enzymes. Encephalopathy, with headache, lethargy, mental confusion, hallucinations, emotional lability, memory loss and delirium may occur; seizures, stupor, convulsions, coma, and death may follow within 24 hours of a severe acute exposure. Dysrhythmias (particularly QTc prolongation and torsade de pointes), cardiomyopathy, ARDS, hepatitis, rhabdomyolysis, hemolysis, and renal failure may develop over several days. The sequence of chronic poisoning involves hyperpigmentation, and eczematoid and allergic dermatitis. muscle fasciculations; gross tremors; ataxia; incoordination; and mental confusion. Muscular weakness, limb tenderness and difficulty walking may follow. The final phase consists of peripheral sensory neuropathy of the hands and feet. That may be associated with a motor neuropathy as well .

Exposure RoutesOral (L2) ; inhalation (L2); dermal (L2)
Toxicity Summary · 1 item

Arsenic and its metabolites disrupt ATP production through several mechanisms. At the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. Hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. Arsenic's carcinogenicity is influenced by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. The binding of other arsenic protein targets may also cause altered DNA repair enzyme activity, altered DNA methylation patterns and cell proliferation. (T1, A17)

Signs and Symptoms · 1 item

Initial signs and symptoms of arsenic ingestion include burning lips, throat constriction and dysphagia, followed by excruciating abdominal pain, hemorrhagic gastritis, gastroenteritis, severe nausea, projectile voting, profuse "rice water-like" diarrhea, with hypovolemia that may result in hypotension and an irregular pulse. The sequence of chronic poisoning involves weakness, anorexia, hepatomegaly, jaundice, and gastrointestinal complaints, followed by conjunctivitis, irritation of the throat and respiratory tract. ther effects of chronic exposure include conjunctivitis with irritation and lacrimation; hair, skin and nail changes; hyperkeratosis of feet and hands; and melanosis, with pigment spots in corneal and conjunctival epithelium. Peripheral nervous system symptoms may include numbness, burning, and tingling of the hands and feet; pain; paresthesias; tenderness .

Safety data

Signal word
Danger
Symbol(GHS)
GHS09,GHS06
Hazard statements
H331-H301-H410
Precautionary statements
P261-P271-P304+P340-P311-P321-P403+P233-P405-P501-P264-P270-P301+P310-P321-P330-P405-P501-P273-P391-P501

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

Arsenic is absorbed mainly by inhalation or ingestion, as to a lesser extent, dermal exposure. It is then distributed throughout the body, where it is reduced into arsenite if necessary, then methylated into monomethylarsenic (MMA) and dimethylarsenic acid (DMA) by arsenite methyltransferase. Arsenic and its metabolites are primarily excreted in the urine. Arsenic is known to induce the metal-binding protein metallothionein, which decreases the toxic effects of arsenic and other metals by binding them and making them biologically inactive, as well as acting as an antioxidant. (L20)

Uses & manufacturing

Uses[4-(aminocarbonyl-amino)phenyl] arsonic acid was used as a drug to treat infections. It is now found in poultry feed and used to treat some avian diseases.

Applications

Usesinsecticide, cholinesterase inhibitor

General DescriptionWhite powder or solid.

Upstream & downstream products

Upstream raw materials

Sodium arsenite solutionARSINE4-Aminophenylarsonic acidWaterSodium cyanateNITARSONE4-NitroanilineCyanogen bromidePotassium cyanate

Additional notes

DefinitionChEBI: [4-(carbamoylamino)phenyl]arsonic acid is a member of ureas.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Carcinogen Classification3, not classifiable as to its carcinogenicity to humans. (L135)